DSM to Manufacture C. difficile Compound for U.K. Biotech Firm
06:14 AM | June 11, 2010 | Deepti Ramesh
DSM BioSolutions, part of the DSM Pharma cluster, says it has entered into an agreement with biotechnology company Novacta Biosystems (Welwyn Garden City, U.K.) for the process development and cGMP...
This information is only available to subscribers.
chemweek.com is the one stop platform for chemical news, data and analysis across all industry sectors and geographies.